09.03.2013 Views

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Protein Tyrosine Kinase (PTK) <strong>Inhibitor</strong>s, continued<br />

Calbiochem • <strong>Inhibitor</strong> SourceBook<br />

Phosphorylation/Dephosphorylation<br />

Product Cat. No. Comments Size Price<br />

TGF-b RI Kinase<br />

<strong>Inhibitor</strong><br />

N TGF-b RI Kinase<br />

<strong>Inhibitor</strong> II<br />

616451 {ALK5 <strong>Inhibitor</strong> I; [3-(Pyridin-2-yl)-4-(4-quinonyl)]-1H-pyrazole; TbR-I <strong>Inhibitor</strong>;<br />

Transforming Growth Factor-b Type I Receptor Kinase <strong>Inhibitor</strong>}<br />

A cell-permeable, potent, selective, ATP-competitive inhibitor of TGF-b type I receptor<br />

tyrosine kinase (IC 50 = 5 nM). Displays ~ 5-fold greater selectivity over p38a MAP<br />

kinase (IC 50 = 740 nM).<br />

616452 [ALK5 <strong>Inhibitor</strong> II; 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine;<br />

Transforming Growth Factor-b Type I Receptor Kinase <strong>Inhibitor</strong> II]<br />

A cell-permeable naphthyridinyl pyrazolo compound that acts as a potent, selective,<br />

and ATP-competitive inhibitor of TGF-b type I receptor (ALK5; IC 50 = 23 nM, 4 nM, and<br />

8 nM for ALK5 binding, ALK5 auto-phosphorylation and TGF-b cellular assay in HepG2<br />

cells, respectively). Minimally affects a panel of nine closely related kinases including<br />

p38 MAPK at IC 50 > 6 mM.<br />

2´-Thioadenosine 589400 (PD 157432)<br />

A potent, selective, and irreversible inhibitor of the ErbB subfamily of protein tyrosine<br />

kinases. Inactivates ErbB by modifying Cys 797 at the active site. Also inhibits ErbB2<br />

(IC 50 = 45 mM).<br />

(-)-Terreic Acid,<br />

Synthetic<br />

581810 {(1R,6S)-3-Hydroxy-4-methyl-7-oxabicyclo[4.1.0]hept-3-ene-2,5-dione}<br />

A cell-permeable, selective inhibitor of Bruton’s tyrosine kinase (BTK; IC 50 = 0 mM<br />

and 3 mM for the basal and activation levels), both in vitro and in vivo.<br />

N TrkA <strong>Inhibitor</strong> 648450 An oxindole compound that acts as a potent and highly selective inhibitor of TrkA<br />

(IC 50 = 6 nM), presumably by targeting the ATP-binding pocket of the kinase. Shown to<br />

exhibit ≥ 00-fold selectivity over c-fms, Cdk , Cdk2, Itk, JNK-3, p38, PDHK4, c-Raf ,<br />

Src, UL 3, and VEGFR2.<br />

TX- 23 655200 [2-((3,5-di-tert-Butyl-4-hydroxyphenyl)-methylene)-4-cyclopentene-1,3-dione]<br />

A cell-permeable inhibitor for Src, eEF2 kinase, and PKA (IC 50 = 2.2, 3.2, and 9.6 mM,<br />

respectively). Inhibits EGFR kinase and PKC only at much higher concentrations<br />

(IC 50 = 320 mM).<br />

N Tyrene CR4 655230 A cell-permeable hydroxystryrylacrylonitrile compound that potently inhibits the kinase<br />

activities of JAK2 and Bcr-Abl (IC 50 ~ 00–600 nM and 500–700 nM, respectively), and<br />

displays selectivity over other related kinases, namely, Btk, Lck, Lyn, Src, Syk, and<br />

ZAP-70 (IC 50 > 5 mM).<br />

Tyrosine-Specific<br />

Protein Kinase <strong>Inhibitor</strong><br />

VEGF Receptor Tyrosine<br />

Kinase <strong>Inhibitor</strong><br />

N VEGF Receptor Tyrosine<br />

Kinase <strong>Inhibitor</strong> II<br />

VEGF Receptor 2 Kinase<br />

<strong>Inhibitor</strong> I<br />

VEGF Receptor 2 Kinase<br />

<strong>Inhibitor</strong> II<br />

VEGF Receptor 2 Kinase<br />

<strong>Inhibitor</strong> III<br />

N InSolution VEGF<br />

Receptor 2 Kinase<br />

<strong>Inhibitor</strong> III<br />

657015 (p60 v-src 137-157 <strong>Inhibitor</strong> Peptide; VAPSDSIQAEEWYFGKITRRE)<br />

Inhibits p60 v-src (IC 50 = 7.5 mM) and epidermal growth factor receptor kinase.<br />

676475 {4-[(4´-Chloro-2´-fluoro)phenylamino]-6,7-dimethoxyquinazoline}<br />

A potent inhibitor of vascular endothelial growth factor (VEGF) receptor (Flt and KDR)<br />

tyrosine kinase activity (IC 50 = 2.0 mM and 00 nM for Flt and KDR, respectively).<br />

676481 {N-(4-Chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide}<br />

Shown to potently inhibit the kinase activities of KDR, Flt- , and c-Kit (IC 50 = 20 nM,<br />

80 nM, and 240 nM, respectively), and minimally inhibit c-Src and EGF-R activities<br />

(IC 50 = 7.0 mM and 7.3 mM). Further, inactive towards the inhibition of CDK- , c-Met,<br />

IGF- R, and PKA (IC 50 > 0 mM).<br />

676480 {(Z)-3-[(2,4-Dimethyl-3-(ethoxycarbonyl)pyrrol-5-yl)methylidenyl]indolin-2-one}<br />

A highly selective, cell-permeable indolin-2-one class of receptor tyrosine kinase<br />

inhibitor (IC 50 = 70 nM) for murine vascular endothelial growth factor receptor 2 (VEGF-<br />

R2; KDR/Flk- ). The inhibition is suggested to be competitive with respect to ATP.<br />

676485 [(Z)-5-Bromo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)-1,3-dihydroindol-2-one]<br />

A cell-permeable receptor tyrosine kinase (RTK) inhibitor [IC 50 = 70 nM for VEGF-R2<br />

(KDR/Flk- ), 920 nM for PDGF-Rb, 4.92 mM for p60 c-src , and 3.3 mM for FGF-R ].<br />

The inhibition is suggested to be competitive with respect to ATP.<br />

676487 {3-[(2,4-Dimethylpyrrol-5-yl)methylidene]-indolin-2-one; SU5416}<br />

A cell-permeable, selective, ATP-competitive inhibitor of VEGF-R (KDR/Flk- ) and<br />

PDGFR kinases (IC 50 = mM and 20 mM, respectively in NIH-3T3 cells overexpressing<br />

Flk- ; K m = 530 nM for ATP).<br />

676498 A 0 mM (500 mg/2 0 ml) solution of VEGF Receptor 2 Kinase <strong>Inhibitor</strong> III<br />

(Cat. No. 676487) in DMSO.<br />

5 mg $ 05<br />

mg $98<br />

2 mg $ 29<br />

2 mg $ 03<br />

mg $ 00<br />

0 mg $90<br />

5 mg $82<br />

500 mg $204<br />

mg $85<br />

5 mg $ 29<br />

mg $99<br />

mg $99<br />

mg $ 8<br />

500 mg $73<br />

Technical Support<br />

Phone 800 628 8470<br />

E-mail calbiochem@emdbiosciences.com<br />

53

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!